73 related articles for article (PubMed ID: 6087414)
1. Experimental studies of latency in vitro by herpes simplex viruses.
Rapp F
Prog Med Virol; 1984; 30():29-43. PubMed ID: 6087414
[No Abstract] [Full Text] [Related]
2. Studies on the molecular biology of herpes simplex virus.
Becker Y
Isr J Med Sci; 1972; 8(8):1216-24. PubMed ID: 4346002
[No Abstract] [Full Text] [Related]
3. Herpes simplex virus latency in SV40 hamster tumour cells.
Boldogh I; Géder L; Váczi L
Acta Microbiol Acad Sci Hung; 1973 Feb; 20(2):127-34. PubMed ID: 4359669
[No Abstract] [Full Text] [Related]
4. Self-limiting infection with herpes simplex virus in cell culture.
Blackmore RV; Morgan HR
Acta Virol; 1967 Jan; 11(1):1-12. PubMed ID: 4382129
[No Abstract] [Full Text] [Related]
5. Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cells.
De Clercq E; Heremans H; Descamps J; Verhelst G; De Ley M; Billiau A
Mol Pharmacol; 1981 Jan; 19(1):122-9. PubMed ID: 7207456
[No Abstract] [Full Text] [Related]
6. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus latency: molecular aspects.
Ho DY
Prog Med Virol; 1992; 39():76-115. PubMed ID: 1317601
[No Abstract] [Full Text] [Related]
8. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
O'Neill FJ; Goldberg RJ; Rapp F
J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
[No Abstract] [Full Text] [Related]
9. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
de Clercq E; Verhelst G; Descamps J; Bergstrom DE
Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
[No Abstract] [Full Text] [Related]
10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the cytopathogenic effects of Herpes simplex virus].
Brouet JL; LOPEZ EV
Rev Sanid Hig Publica (Madr); 1974 Jun; 48(6):553-9. PubMed ID: 4374739
[No Abstract] [Full Text] [Related]
13. Herpes simplex infection of HEp-2 and L-929 cells. 2. The kinetics of virus multiplication and cell lysis, and the measurement of interferon production.
Underwood PA
Microbios; 1972; 5(19):167-76. PubMed ID: 4361838
[No Abstract] [Full Text] [Related]
14. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
[TBL] [Abstract][Full Text] [Related]
15. Trans-activation of herpes simplex virus type 1 immediate early genes is specifically inhibited by human recombinant interferons.
De Stasio PR; Taylor MW
Biochem Biophys Res Commun; 1989 Mar; 159(2):439-44. PubMed ID: 2539110
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies of a co-carcinogenic effect of vaccinia and herpes group viruses.
Mazurenko NP; Merekalova ZI; Pavlish OA; Bykovsky AF; Kurzman MJ; Mazurenko NN
Neoplasma; 1981; 28(4):403-12. PubMed ID: 6270580
[TBL] [Abstract][Full Text] [Related]
17. [Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro].
Wang JB; Ge J; Liu BQ; Huang B; Wei YT
Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):212-7. PubMed ID: 16643751
[TBL] [Abstract][Full Text] [Related]
18. Repression and activation of the genome of herpes simplex viruses in human cells.
Wigdahl BL; Isom HC; Rapp F
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6522-6. PubMed ID: 6273875
[TBL] [Abstract][Full Text] [Related]
19. A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation.
Samoto K; Perng GC; Ehtesham M; Liu Y; Wechsler SL; Nesburn AB; Black KL; Yu JS
Cancer Gene Ther; 2001 Apr; 8(4):269-77. PubMed ID: 11393279
[TBL] [Abstract][Full Text] [Related]
20. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
